[Federal Register Volume 72, Number 74 (Wednesday, April 18, 2007)]
[Notices]
[Page 19521]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E7-7340]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the Advisory Committee on Blood Safety and 
Availability

AGENCY: Department of Health and Human Services, Office of the 
Secretary.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the U.S. 
Department of Health and Human Services is hereby giving notice that 
the Advisory Committee on Blood Safety and Availability (ACBSA) will 
hold a meeting. The meeting will be open to the public on both 
Thursday, May 10 and Friday, May 11, 2007.

DATES: The meeting will take place Thursday, May 10, 2007 and Friday, 
May 11, 2007 from 9 a.m. to 5 p.m.

ADDRESSES: Georgetown University Conference Center, 3800 Reservoir 
Road, NW., Washington, DC 20057.

FOR FURTHER INFORMATION CONTACT: Jerry A. Holmberg, PhD, Executive 
Secretary, Advisory Committee on Blood Safety and Availability, Office 
of Public Health and Science, Department of Health and Human Services, 
1101 Wootton Parkway, Room 250, Rockville, MD 20852, (240) 453-8803, 
FAX (240) 453-8456, e-mail [email protected].

SUPPLEMENTARY INFORMATION: The ACBSA will receive updates on previous 
recommendations to include variant Creutzfeldt Jacob Disease (vCJD), 
Chagas, Transfusion Related Acute Lung Injury (TRALI) and West Nile 
Virus.
    Since the last meeting, the Committee's Charter was modified and 
approved by Secretary Leavitt in October 2006 to include broad public 
health, ethical and legal issues related to transfusion and 
transplantation safety. In order to understand these areas of 
commonality, the main topic of this meeting will center on 
presentations and discussion of common concerns in transfusion and 
transplantation safety.
    The new charter permits the expansion of the Committee ex-officio 
members to include agencies other than those currently having a 
permanent ex-officio seat. Representation from the Division of Organ 
Transplantation within the Health Resources and Services Administration 
(HRSA) and the Office of Cellular, Tissue, and Gene Therapy within the 
Food and Drug Administration (FDA) will be added as Committee ex-
officio members.
    Public comment will be solicited on Thursday, May 10, at noon and 
Friday, May 11, before noon. Comments will be limited to five minutes 
per speaker. Anyone planning to comment is encouraged to contact the 
Executive Secretary at his/her earliest convenience. Those who wish to 
have printed material distributed to Advisory Committee members should 
submit thirty (30) copies to the Executive Secretary prior to close of 
business May 7, 2007. Likewise, those who wish to utilize electronic 
data projection to the Committee must submit their materials to the 
Executive Secretary prior to close of business May 7, 2007.

    Dated: April 13, 2007.
Jerry A. Holmberg,
Executive Secretary, Advisory Committee on Blood Safety and 
Availability.
 [FR Doc. E7-7340 Filed 4-17-07; 8:45 am]
BILLING CODE 4150-41-P